Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Vγ9Vδ2 T cells strengthen cisplatin inhibition activity against breast cancer MDA-MB-231 cells by disrupting mitochondrial function and cell ultrastructure

Fig. 2

a Flow cytometry plot analyses of MDA-MB-231 cell viability in the context of treatment of cis-platinum (CDDP) plus Vγ9Vδ2 T cells, showing data of one time of experiment. b Statistical data from triple repetitions of experiments, showing that Vγ9Vδ2 T cells could significantly strengthen CDDP cytotoxicity against MDA-MB-231. c Flow cytometry plot data of reactive oxygen species (ROS) production from one time of experiment. d Triple repetitions, clearly indicating that Vγ9Vδ2 T cells could dramatically strengthen CDDP-induced reduction of ROS production of in MDA-MB-231 cells. *p < 0.05; **P < 0.01; ***P < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us